Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
Baber U, Sartori S, Aquino M, Kini A, Kapadia S, Weiss S, Strauss C, Muhlestein JB, Toma C, Rao SV, DeFranco A, Poddar KL, Chandrasekhar J, Weintraub W, Henry TD, Bansilal S, Baker BA, Marrett E, Keller S, Effron M, Pocock S, Mehran R. Baber U, et al. Among authors: bansilal s. Am Heart J. 2017 Jun;188:73-81. doi: 10.1016/j.ahj.2017.02.013. Epub 2017 Feb 21. Am Heart J. 2017. PMID: 28577683
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
Mennuni MG, Halperin JL, Bansilal S, Schoos MM, Theodoropoulos KN, Meelu OA, Sartori S, Giacoppo D, Bernelli C, Moreno PR, Krishnan P, Baber U, Lucarelli C, Dangas GD, Sharma SK, Kini AS, Tamburino C, Chieffo A, Colombo A, Presbitero P, Mehran R. Mennuni MG, et al. Among authors: bansilal s. Am J Cardiol. 2015 Jul 1;116(1):37-42. doi: 10.1016/j.amjcard.2015.03.033. Epub 2015 Apr 8. Am J Cardiol. 2015. PMID: 25956624
Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
Chandrasekhar J, Mastoris I, Baber U, Sartori S, Schoos M, Bansilal S, Dangas G, Mehran R. Chandrasekhar J, et al. Among authors: bansilal s. Am Heart J. 2015 Dec;170(6):1234-42. doi: 10.1016/j.ahj.2015.08.023. Epub 2015 Sep 21. Am Heart J. 2015. PMID: 26678646 Clinical Trial.
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
Chandrasekhar J, Bansilal S, Baber U, Sartori S, Aquino M, Farhan S, Vogel B, Faggioni M, Giustino G, Ariti C, Colombo A, Chieffo A, Kini A, Saporito R, Michael Gibson C, Witzenbichler B, Cohen D, Moliterno D, Stuckey T, Henry T, Pocock S, Dangas G, Gabriel Steg P, Mehran R. Chandrasekhar J, et al. Among authors: bansilal s. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E217-E225. doi: 10.1002/ccd.26716. Epub 2016 Sep 21. Catheter Cardiovasc Interv. 2017. PMID: 27650638
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Faggioni M, Baber U, Chandrasekhar J, Sartori S, Weintraub W, Rao SV, Vogel B, Claessen B, Kini A, Effron M, Ge Z, Keller S, Strauss C, Snyder C, Toma C, Weiss S, Aquino M, Baker B, Defranco A, Bansilal S, Muhlestein B, Kapadia S, Pocock S, Poddar KL, Henry TD, Mehran R. Faggioni M, et al. Among authors: bansilal s. Catheter Cardiovasc Interv. 2019 Jul 1;94(1):53-60. doi: 10.1002/ccd.28033. Epub 2019 Jan 17. Catheter Cardiovasc Interv. 2019. PMID: 30656812
Resistant in-stent restenosis in the drug eluting stent era.
Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS. Theodoropoulos K, et al. Among authors: bansilal s. Catheter Cardiovasc Interv. 2016 Nov;88(5):777-785. doi: 10.1002/ccd.26559. Epub 2016 May 17. Catheter Cardiovasc Interv. 2016. PMID: 27184223
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials.
Giacoppo D, Madhavan MV, Baber U, Warren J, Bansilal S, Witzenbichler B, Dangas GD, Kirtane AJ, Xu K, Kornowski R, Brener SJ, Généreux P, Stone GW, Mehran R. Giacoppo D, et al. Among authors: bansilal s. Circ Cardiovasc Interv. 2015 Aug;8(8):e002475. doi: 10.1161/CIRCINTERVENTIONS.114.002475. Circ Cardiovasc Interv. 2015. PMID: 26198286 Clinical Trial.
Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials.
Giustino G, Mehran R, Bansilal S, Feit F, Lincoff M, Deliargyris EN, Kirtane AJ, Généreux P, Redfors B, Prats J, Bernstein D, Brener SJ, Skerjanec S, Lansky AJ, Francese DP, Dangas GD, Stone GW. Giustino G, et al. Among authors: bansilal s. Am J Cardiol. 2016 Jul 1;118(1):6-16. doi: 10.1016/j.amjcard.2016.04.005. Epub 2016 Apr 20. Am J Cardiol. 2016. PMID: 27181566 Clinical Trial.
81 results